Recombinant Human Endothelial-MonocyteAActivating Polypeptide II (rHuEMAP-II)

Produktübersicht

• Artikelname: Recombinant Human Endothelial-MonocyteAActivating Polypeptide II (rHuEMAP-II)
• Artikelnummer: BWT-PR1015
• Hersteller Artikelnummer: PR1015
• Alternativnummer: BWT-PR1015-5UG,BWT-PR1015-20UG,BWT-PR1015-1.0MG
• Hersteller: Bioworld Technology
• Kategorie: Biochemikalien

Produktbeschreibung

EMAP-II is a tumor derived cytokine that exerts a wide range of activities on endothelial cells, monocytes and neutrophils. EMAP-II inhibits endothelial cell proliferation, vasculogenesis, neovessel formation, and can induce apoptosis. It is also chemota

Produkteigenschaften

• Molekulargewicht: Approximately 18.3 KDa, a single non-glycosylated polypeptide chain containing 166 amino acids.
• Quelle: Escherichia coli.
• Reinheit: >98% by SDS-PAGE and HPLC analyses.
• Formulierung: Sterile Filtered White lyophilized (freeze-dried) powder.
• Sequenz: SKPIDVSRLD LRIGCIITAR KHPDADSLYV EEVDVGEIAP RTVVSGLVNH VPLEQMQNRM VILLCNLKPA KMRGVLSQAM VMCASSPEKI EILAPPNGSV PGDRITFDAF PGEPDKELNP KKKIWEQIQP DLHTNDECVA TYKGVPFEVK GKGVCRAQTM SNSGIK
• Formel: Lyophilized from a 0.2mm filtered concentrated solution in 20mM PB, pH 7.4, 130mM NaCl.

Anwendungsbeschreibung

• Anwendungsbeschreibung: We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportio